The Impact of Toll‐Like Receptor 5 on Liver Function in Age‐Related Metabolic Disorders
Aging Cell · 2025
DOI: 10.1111/acel.70009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Dong-Hyun Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: MediSpan, Inc, Bundang-gu, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Liver, Toll-Like Receptor 5, Metabolic Diseases, Aging. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Korea Drug Development Fund.
Abstract (Originalsprache)
Toll‐like receptor 5 (TLR5) plays a critical role beyond its traditional function in innate immunity, significantly impacting metabolic regulation and liver health. Previously, we reported that TLR5 activation extends the healthspan and lifespan of aging mice. This study demonstrates that TLR5 deficiency leads to pronounced metabolic abnormalities with age, primarily affecting liver metabolic functions rather than intestinal inflammation. Comprehensive RNA sequencing analysis revealed that TLR5 deficiency induces gene expression changes in liver tissue similar to those caused by the methionine–choline deficient (MCD) diet, particularly affecting lipid metabolism and circadian rhythm‐related genes. TLR5 knockout (TLR5 KO) mice displayed an increased propensity for liver fibrosis and lipid accumulation under the MCD diet, exacerbating liver pathology. Both hepatocytes and hepatic stellate cells in TLR5 KO mice were functionally impacted, leading to metabolic dysfunction and fibrosis. These findings suggest that TLR5 could be a significant target for addressing metabolic diseases that arise and worsen with aging. Furthermore, understanding the mechanisms by which TLR5 activation extends healthspan could provide valuable insights into therapeutic strategies for enhancing longevity and managing age‐related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MediSpan, Inc, Bundang-gu, Gyeonggi-do, Republic of Korea.
- Department of Biochemistry, Chonnam National University Medical School, Hwasun-gun, Jeonnam-do, Republic of Korea.
- Center for Creative Biomedical Scientists, Chonnam National University Medical School, Hwasun-gun, Jeonnam-do, Republic of Korea.
- Department of Biochemistry, Konkuk University School of Medicine, Seoul, South Korea.
- Future Life and Society Research Center, Chonnam National University Medical School, Hwasun-gun, Jeonnam-do, Republic of Korea.
ORCID-Profile: Kyung A Cho
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Korea Drug Development Fund
Zitieren
APA
Kim, D. H., Go, H. S., Jeon, E. J., Nguyen, T. Q. T., Kim, D. Y., Park, H., Eom, H. J., Kim, S. Y., Park, S. C., & Cho, K. A. (2025). The Impact of Toll‐Like Receptor 5 on Liver Function in Age‐Related Metabolic Disorders. Aging Cell. https://doi.org/10.1111/acel.70009
Vancouver
Kim DH, Go HS, Jeon EJ, Nguyen TQT, Kim DY, Park H, et al. The Impact of Toll‐Like Receptor 5 on Liver Function in Age‐Related Metabolic Disorders. Aging Cell. 2025. doi:10.1111/acel.70009
BibTeX
@article{Kim2025,
author = {Kim, Dong-Hyun and Go, Hye Sun and Jeon, Eun Jae and Nguyen, Thi Quynh Trang and Kim, Da Yeon and Park, Hansung and Eom, Hyo-Ji and Kim, Sung Young and Park, Sang Chul and Cho, Kyung A},
title = {The Impact of Toll‐Like Receptor 5 on Liver Function in Age‐Related Metabolic Disorders},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70009}
}
EUVIMED